Title
The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19
Document Type
Letter to the Editor
Publication Date
9-28-2020
Publication Source (Journal or Book title)
Glycobiology
First Page
763
Last Page
767
Recommended Citation
Laine, R. A. (2020). The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19. Glycobiology, 30 (10), 763-767. https://doi.org/10.1093/glycob/cwaa083
COinS